Founded October 2015
Stage Technology development
Investor The Trendlines Group
CEO Nissim Chen, PhD
AquiNovo’s novel growth enhancers for farmed fish to meet the ever-growing demand for fish protein. Our non-GMO, non-hormonal, easy-to-use solution accelerates fish growth and thus provide fish farms with shorter time to market and higher yields.
The first two products target tilapia and salmon; future products are planned for additional species. AquiNovo intends to sell its products to feed producers (incorporated into their feed and sold through their marketing and sales networks).
AquiNovo brings a disruptive technology to a growing industry, addressing a critical challenge of the immense food crises.
Applications filed worldwide
Aquaculture production is expanding rapidly as marine sources are depleted and fish consumption increases. To meet the growing demand for fish protein, the aquaculture industry needs sustainable solutions that increase fish yields while using existing resources and infrastructures. The technology was demonstrated in both lab scale (yielding 20%-40% growth enhancement) and field scale studies.
Non-GMO, non-hormonal technology for accelerating fish growth • Shorter time to market, increased yields > increased revenues • Estimated market potential: 50+million tonnes
AquiNovo CEO Nissim Chen interviewed on Israel Daily TV.
Nissim Chen presents at AgriVest 2018 in Tel Aviv
Over 17 years’ experience in technology commercialization and international business development in biotech and agbio; former VP Business Development, FuturaGene Group; Director of Business Development, Ramot, Tel Aviv University technology transfer company; PhD, biology, Hebrew University of Jerusalem; MBA, Tel Aviv University
Expert manager with proven track record in strategic planning, production, and operations in pharmaceutical and chemical industries; former CEO, ChemAgis and Agis Industries; board member of various biotech firms; MSc, mechanical engineering, Ben-Gurion University of the Negev; BSc, chemical engineering Technion-Israel Institute of Technology
fish endocrinology and neurology, strong scientific track record as well as lab establishment and management; PhD, biology, Tel Aviv University; MSc and BSc, animal sciences, Agriculture Faculty, Hebrew University of Jerusalem
Professor, Hebrew University Department of Animal Sciences; world-renowned specialist in fish reproduction; research focused on endocrine axis that leads to fish reproduction; 91 publications; 2 patents; PhD, MSc, zoology; BSc, life sciences, all from Tel Aviv University; Kaye Award winner
Professor Emeritus, Hebrew University Faculty of Science; world-renowned expert in organic chemistry; research focused on molecular mechanism of memory, development of technologies for conversion of bioactive peptides and active regions in proteins into drugs, and signal transduction therapy; co-founder and consultant to biotech companies; 270 peer-reviewed publications; 40 patents; PhD, Hebrew University of Jerusalem
With feed comprising up to 50% of growers’ operating expenses, the goal of reaching maximum fish weight while reducing production costs remains a key challenge. AquiNovo’s technology addresses this challenge by enhancing growth, thus reducing time to marketing and increasing overall fish production efficiency.
AquiNovo’s first products will be developed for tilapia, a high-demand market with an expected 8.5 million tons farmed at year of launch; and salmon, a high-value market with an expected 6.4 million tons farmed at launch.